By Jason M. Brocks, Legal Analyst,Bloomberg Law A recent U.S. District Court decision emphasizes the importance to research sponsors and contract research organizations(CROs) of understanding the terms set out in their agreements, particularly those terms relating to the responsibilities of each party upon termination of the arrangement. Pharmaceutical, medical device and biotechnology companies that sponsor [...]
Today’s euro-area bank-deposit figures for March may highlight the extent of the bank run in Cyprus even as a proposed deposit levy on savers was dropped after lawmakers refused to implement it. Greek’s deposit-growth rate turned positive for the first time in three years in February. Four nations experienced a drop in deposits on a year-over-year basis in February: [...]
CLICK HERE FOR MORE
A systemically important financial institution designation for the three largest U.S. insurers — MetLife Inc., Prudential Financial Inc., and American International Group Inc. — may put them at a disadvantage to their competitors. Click here to continue reading.
Foreign institutional investors bought $179 million of equities across India, Indonesia, South Korea, the Philippines, Taiwan, Thailand and Vietnam in the week to Wednesday, compared with net sales of about $440 million the week prior. Click here to continue reading.
Bloomberg Municipal Market Q1 StatBook from Bloomberg Briefs Take a trial to our market leading Municipal Market newsletter - click here.
By Sabrina Willmer Mount Kellett Capital Management, founded by two former Goldman Sachs Group Inc. executives, plans to raise a new fund matching the $4 billion gathered in 2012 for its last global special situations vehicle, according to two people familiar with the situation. Mount Kellett Capital Partners Fund III, which is targeting a first [...]
CLICK HERE FOR MORE
by Andrew Berens, MD, Senior Healthcare Analyst and Grace Guo, Bloomberg Industries Avanir’s Nuedexta may receive a decision from the Committee for Medicinal Products for Human Use (CHMP) this week as a treatment for pseudobulbar affect (PBA). Approval in the EU would be the second regulatory nod for the drug. PBA is also called emotional [...]